Search Within

Neeta Pandit-Taskar

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
  3. Review (1)
Groups
  1. Department of Medicine (15)
  2. Melanoma and Immunotherapeutics Service (15)
  3. Molecular Imaging and Therapy Service (15)
  4. Radiology, Department of (15)
  5. Solid Tumor Oncology Division (15)
  6. GSK Faculty (11)

More Groups

People
  1. Michael Postow (8)
  2. Jedd Wolchok (6)
  3. Joseph O'Donoghue (5)
  4. James Harding (4)
  5. Jason Lewis (4)
  6. Matthew Hellmann (4)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Journal for ImmunoTherapy of Cancer (3)
  3. Journal of Nuclear Medicine (3)
  4. Cancer Research (1)
  5. Clinical Cancer Research (1)
  6. Investigational New Drugs (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Biomed Central Ltd (3)
  3. Society of Nuclear Medicine (3)
  4. American Association for Cancer Research (2)
  5. American Chemical Society (1)
  6. Elsevier Inc. (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody (Mb) 89Zr-IAB22M2C, in advanced solid tumors
    Meeting Abstract

    Postow, M. A.; Harding, J. J.; Hellmann, M. D.; Gordon, M. S.; Tsai, F.; Donoghue, J. A. O.; Lewis, J. S.; Wu, A. M.; Le, W.; Korn, R. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
    Journal Article

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E. W.; Wu, B. W.; Bomalaski, J. S.; Venhaus, R.; Pan, L.; Old, L. J.; more...
    Investigational New Drugs (2013)

    Fulltext@MSK | Save
  • Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM)
    Meeting Abstract

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E.; Venhaus, R.; Pan, L.; Old, L.; Pavlick, A. C.; Wolchok, J. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save